The France respiratory devices market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 6.5% during 2023–2031. The growth of the market is attributed to the increase in the number of asthma, tuberculosis, chronic obstructive pulmonary disease, and pneumonia cases. Increasing aging population, rising pollution levels, changing lifestyles, and high prevalence of smoking are expected to spur the market.
Respiratory devices supply respiratory gas mechanically to patients with impaired respiratory functions. Respiratory devices are used for the management, control, evaluation, diagnostic, care, and treatment of the patients having cardiopulmonary abnormalities. There are various degenerative lung diseases such as emphysema, asthma, chronic and acute respiratory diseases that requires respiratory devices for treatment.
Respiratory devices help to exclude mucus from the respiratory airways and also augment pulmonary functions. According to French government agency, Business France, the country ranked as fourth globally and second in Europe for medical device and technology market. According to World Health Organization (WHO), choice obstructive pulmonary diseases are major health concern and are one of the leading causes of death.
France Respiratory Devices Market Trends, Drivers, Restraints, and Opportunities
-
Increasing demand for homecare therapeutic devices is projected to drive the market expansion in the coming years.
-
Rapid growth of the healthcare sector is main factor pushing the market growth.
-
High cost of respiratory devices is estimated to impede the market expansion during the forecast period.
-
Lack of awareness regarding various diseases and its treatments act as major challenge that can hinder the market growth.
-
R&D investment and technological advancement in the respiratory devices is expected to create significant opportunities for the market players.
Scope of France Respiratory Devices Market Report
The report on the France respiratory devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
France Respiratory Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Types (Therapeutic Devices [Inhalers, Oxygen Concentrators, Humidifiers, CPAP Devices, Ventilators, Nebulizers, BiPAP Devices, and Others], Diagnostic and Monitoring Devices [Capnographs, Peak Flow Meters, Spirometers, Pulse Oximeters, Sleep Test Devices, and Others], and Disposables [Breathing Circuits and Masks]), End-users (Hospitals and Homecare)
|
Country
|
France
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Chiesi farmaceutici S.P.A.; 3M; Dragerwerk AG; GE Healthcare; Invacare Corporation; Medtronic PLC; Fisher & Paykel Healthcare Limited; ResMed Corporation; Novartis AG; and Air Liquide S.A.
|
France Respiratory Devices Market Segment Insights
Therapeutic devices segment is projected to account for a large market share
Based on types, the France respiratory devices market is divided into therapeutic devices, diagnostic and monitoring devices, and disposables. The therapeutic devices segment is further bifurcated into inhalers, oxygen concentrators, humidifiers, CPAP devices, ventilators, nebulizers, BiPAP devices, and others. The diagnostic and monitoring devices segment is further classified into capnographs, peak flow meters, spirometers, pulse oximeters, sleep test devices, and others. The disposables segment is further categorized as breathing circuits and masks.
The therapeutic devices segment is expected to constitute a key share of the market during the forecast period owing to increasing demand for ventilators, inhalers and oxygen concentrators and high incidences of asthma. Inhalers are highly used in the treatment of major respiratory ailments. However, the diagnostic and monitoring devices segment is anticipated to expand at a rapid pace during the forecast period due to rising burden of respiratory disorders and easier to use is increasing adoption in homecare and hospitals.
Hospitals segment is projected to hold a key market share
On the basis of end-users, the market is segmented into hospitals and homecare. The hospitals segment is expected to represent a key share of the market in the coming years due to rising developments in healthcare infrastructure, improving access to healthcare services, and increasing partnerships of private and public for better healthcare services. On the other hand, the homecare segment is anticipated to expand at a rapid pace during the forecast period owing to covid-19 various people are demanding for homecare treatments.
Segments
The France respiratory devices market has been segmented on the basis of
Types
- Therapeutic Devices
- Inhalers
- Oxygen Concentrators
- Humidifiers
- CPAP Devices
- Ventilators
- Nebulizers
- BiPAP Devices
- Others
- Diagnostic and Monitoring Devices
- Capnographs
- Peak Flow Meters
- Spirometers
- Pulse Oximeters
- Sleep Test Devices
- Others
- Disposables
End-users
Country
Key Players
- Chiesi farmaceutici S.P.A.
- 3M
- Dragerwerk AG
- GE Healthcare
- Invacare Corporation
- Medtronic PLC
- Fisher & Paykel Healthcare Limited
- ResMed Corporation
- Novartis AG
- Air Liquide S.A.
Competitive Landscape
Key players competing in the France respiratory devices market include Chiesi farmaceutici S.P.A.; 3M; Dragerwerk AG; GE Healthcare; Invacare Corporation; Medtronic PLC; Fisher & Paykel Healthcare Limited; ResMed Corporation; Novartis AG; and Air Liquide S.A. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.